Boehringer Ingelheim

(IN BRIEF) Deutsche Bank was honored with several awards at The Asset Triple A Treasurise Awards 2025, including Best Liquidity Management Bank and Best Structured Trade Finance Bank. The bank also received recognition as the Best Transaction Bank in China … Read the full press release →

(IN BRIEF) Boehringer Ingelheim has entered into a multi-year collaboration with Cue Biopharma to develop and commercialize CUE-501, a first-in-class bispecific compound designed to selectively deplete harmful B cells in autoimmune diseases. The innovative therapy uses Cue’s Immuno-STAT™ platform to … Read the full press release →

(IN BRIEF) Boehringer Ingelheim, via its subsidiary NBE Therapeutics, has launched a cutting-edge ADC research and development facility in Basel with a CHF 27 million investment. The center is a key part of the company’s strategic efforts to advance next-generation … Read the full press release →